Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John P. Hamill Insider Profile
11 Followers
John P. Hamill, Interim CFO at Cellectar Biosciences, holds ― shares in Cellectar Biosciences (Ticker: CLRB), holds 18.87K shares in Aprea Therapeutics (Ticker: APRE), holds 72.80K shares in Windtree Therapeutics (Ticker: WINT). Most recently, John P. Hamill ― shares of Cellectar Biosciences on ― for an estimated value of ―.
John P. Hamill Cellectar Biosciences (CLRB)Interim CFO
Cellectar Biosciences (CLRB)
Interim CFO
Ranked #91,254 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-40.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John P. Hamill holds in companies
Most Profitable Insider Trade
The most profitable trade made by John P. Hamill
John P. Hamill's Trading History
Cellectar Biosciences
―
Interim CFO
―
―
Trevena
Jun 04, 2019
VP Fin,Princ Fin&Acct Officer
Informative Buy
8.70K
$33.88K
Windtree Therapeutics
Jul 26, 2022
SVP & CFO
Informative Buy
1.08K
$359.63K
Aprea Therapeutics
Mar 28, 2024
SrVP/CFO/Prin Fin & Acct Ofcr
Uninformative Buy
―
$100.94K
List of latest transactions for each holding click on a transaction to see John P. Hamill's performance on stock
You May Also Like
John P. Hamill insider profile FAQ
What is the percentage of profitable transactions made by John P. Hamill?
The percentage of profitable transactions made by John P. Hamill is 17%.
What is the average return per transaction made by John P. Hamill?
The average return per transaction made by John P. Hamill is -40.70%.
What stocks does John P. Hamill hold?
John P. Hamill holds: CLRB, TRVN, WINT, APRE stocks.
What was John P. Hamill’s latest transaction?
John P. Hamill latest transaction was an Uninformative Buy of ―.
What was John P. Hamill's most profitable transaction?
John P. Hamill’s most profitable transaction was an Informative Buy of TRVN stock on June 4, 2019. The return on the trade was 19.80%.
What is John P. Hamill's role in Cellectar Biosciences?
John P. Hamill's role in Cellectar Biosciences is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.